0001676950-18-000001.txt : 20180131 0001676950-18-000001.hdr.sgml : 20180131 20180131112219 ACCESSION NUMBER: 0001676950-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180131 DATE AS OF CHANGE: 20180131 EFFECTIVENESS DATE: 20180131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akriveia Therapeutics, LLC CENTRAL INDEX KEY: 0001676950 IRS NUMBER: 812665651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-304462 FILM NUMBER: 18561554 BUSINESS ADDRESS: STREET 1: 23 SOUTHERN HILLS DRIVE CITY: SKILLMAN STATE: NJ ZIP: 08558 BUSINESS PHONE: 609-560-0927 MAIL ADDRESS: STREET 1: 23 SOUTHERN HILLS DRIVE CITY: SKILLMAN STATE: NJ ZIP: 08558 D 1 primary_doc.xml X0708 D LIVE 0001676950 Akriveia Therapeutics, LLC 23 SOUTHERN HILLS DRIVE SKILLMAN NJ NEW JERSEY 08558 609-560-0927 DELAWARE None None Limited Liability Company true 2016 Simon Tomlinson c/o Akriveia Therapeutics, LLC 23 Southern Hills Drive Skillman NJ NEW JERSEY 08558 Executive Officer Director Thomas Beck c/o Akriveia Therapeutics, LLC 23 Southern Hills Drive Skillman NJ NEW JERSEY 08558 Director Benjamin Auspitz c/o Akriveia Therapeutics, LLC 23 Southern Hills Drive Skillman NJ NEW JERSEY 08558 Director David Grayzel c/o Akriveia Therapeutics, LLC 23 Southern Hills Drive Skillman NJ NEW JERSEY 08558 Director Michael Gladstone c/o Akriveia Therapeutics, LLC 23 Southern Hills Drive Skillman NJ NEW JERSEY 08558 Director Biotechnology Decline to Disclose 06b false 2018-01-23 false true false 0 22500000 3000000 19500000 false 1 0 0 0 false Akriveia Therapeutics, LLC /s/ Simon Tomlinson Simon Tomlinson Manager 2018-01-31